Myriad Genetics (MYGN) PT Raised to $35 at Leerink Partners, 'Core Business Still Stabilizing But GeneSight Remains Key LT'

February 7, 2018 6:04 AM

Leerink Partners raised its price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found